Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.
During infection, Cryptococcus neoformans capsular glucuronoxylomannan (GXM) is released into tissues, where it may be associated with a variety of deleterious immunological effects. Relatively little is known about the organ distribution and cellular localization of GXM antigen. Intravenous adminis...
Gardado en:
| Publicado en: | Infect Immun |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1995
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC173475/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7642276/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.63.9.3448-3453.1995 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
